Lifeboat Foundation

Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=K78jqx9fx2I
Please support this podcast by checking out our sponsors:
- Mizzen+Main: https://mizzenandmain.com and use code LEX to get $35 off.
- NI: https://www.ni.com/perspectives.
- GiveDirectly: https://givedirectly.org/lex to get gift matched up to $300
- Indeed: https://indeed.com/lex to get $75 credit.
- Blinkist: https://blinkist.com/lex and use code LEX to get 25% off premium.

GUEST BIO:
Jamie Metzl is an author specializing in topics of genetic engineering, biotechnology, and geopolitics.

Continue reading “Sam Harris and Brett Weinstein Twitter feud | Jamie Metzl and Lex Fridman” »

Try Dashlane here: https://www.dashlane.com/isaacarthur.
Get 10% off now with my promo code: isaacarthur.
Genetic Engineering and DNA alteration is an emerging technology with huge ramifications in the future, including potentially altering the DNA of adult humans, not just embryos or plants & animals.

Visit our Website: http://www.isaacarthur.net.
Support us on Patreon: https://www.patreon.com/IsaacArthur.
SFIA Merchandise available: https://www.signil.com/sfia/
Social Media:
Facebook Group: https://www.facebook.com/groups/1583992725237264/
Reddit: https://www.reddit.com/r/IsaacArthur/
Twitter: https://twitter.com/Isaac_A_Arthur on Twitter and RT our future content.
SFIA Discord Server: https://discord.gg/53GAShE

Continue reading “DNA Manipulation in Living Subjects” »

Yesterday’s longevity AMA: michael lustgarten, phd.

Questionsabout yesterday’s video, and more…AMA!

Continue reading “AMA Live Stream #1” »

The earliest genetic traces of Native American ancestry among Polynesians.

The peopling of Polynesia was a stunning achievement: Beginning around 800 C.E., audacious Polynesian navigators in double-hulled sailing canoes used the stars and their knowledge of the waves to discover specks of land separated by thousands of kilometers of open ocean. Within just a few centuries, they had populated most of the Pacific Ocean’s far-flung islands. Now, researchers have used modern DNA samples to trace the exploration in detail, working out what order the islands were settled in and dating each new landfall to within a few decades.

“The whole question of the settlement of Polynesia has been going on for 200 years,” says University of Hawaii, Manoa, archaeologist Patrick Kirch, who was not involved in the research. “This is a really great paper, and I’m happy to see it.”

Continue reading “‘No one could have predicted.’ DNA offers surprises on how Polynesia was settled” »

And some of the genetic programming for this regenerative superpower may have been passed down to humans.

Chinese scientists developed a targeted delivery system that can conduct precise gene-editing for inflammatory bowel disease. /CFP

Chinese scientists have developed a targeted delivery system that can bring gene-editing tools to colon cells, offering a precise cure for inflammatory bowel disease.

The study, published on Thursday in the journal Science Advances, reported a CRISPR-Cas9 prodrug nanosystem that can transport a gene-editing protein exclusively to inflammatory lesions in mice colons and then “switch on” the protein.

Many intractable diseases are the result of a genetic mutation. Genome editing technology promises to correct the mutation and thus new treatments for patients. However, getting the technology to the cells that need the correction remains a major challenge. A new study led by CiRA Junior Associate Professor Akitsu Hotta and in collaboration with Takeda Pharmaceutical Company Limited as part of the T-CiRA Joint Research Program reports how lipid nanoparticles provide an effective means for the delivery to treat Duchenne muscular dystrophy (DMD) in mice.

Last year’s Nobel Prize for Chemistry to the discoverers of CRISPR-Cas9 cemented the impact of genome editing technology. While CRISPR-Cas9 can be applied to agriculture and livestock for more nutritious food and robust crops, most media attention is on its medical potential. DMD is just one of the many diseases that researchers foresee a treatment using CRISPR-Cas9.

“Oligonucleotide drugs are now available for DMD, but their effects are transient, so the patient has to undergo weekly treatments. On the other hand, CRISPR-Cas9 effects are long lasting,” said Hotta.

Gene therapy is a powerful developing technology that has the potential to address myriad diseases. For example, Huntington’s disease, a neurodegenerative disorder, is caused by a mutation in a single gene, and if researchers could go into specific cells and correct that defect, theoretically those cells could regain normal function.

A major challenge, however, has been creating the right “delivery vehicles” that can carry genes and molecules into the cells that need treatment, while avoiding the cells that do not.

Now, a team led by Caltech researchers has developed a gene-delivery system that can specifically target brain cells while avoiding the liver. This is important because a gene therapy intended to treat a disorder in the brain, for example, could also have the side effect of creating a toxic immune response in the liver, hence the desire to find delivery vehicles that only go to their intended target. The findings were shown in both mouse and marmoset models, an important step towards translating the technology into humans.

A new technology is allowing one company to produce full-spectrum cannabis without growing the plant itself.

Sounds like something out of a science fiction movie, but it’s very real. In what could be a global first, this week, a publicly traded Canadian-Israeli biotech firm company, BioHarvest Sciences, will announce that it has managed to produce at least 10kg of full-spectrum cannabis without the plant itself.

According to information procured exclusively, the biomass in question was created using the company’s proprietary BioFarming technology platform, which allows it to grow natural plant cells in bioreactors. In addition, management assures, the product is not genetically modified, and is “uniquely consistent and clean.” This could provide an interesting solution to two of the cannabis industry’s main pain points: product variability and contamination — the aseptic, controlled environment means the product isn’t affected by fungi, yeast, mold or any other contaminants or pesticides.

Continue reading “Producing Cannabis Biomass Without Growing A Cannabis Plant: How One Company Is Doing It” »